Information Blocking: Everything Providers Should Know to Ensure Compliance

Why This Topic Matters

Providers and health organizations need to understand these requirements to reduce compliance risk, support access to electronic health information, and prepare internal processes for the rule’s expectations and exceptions.

Article Sections

1. Overview of the Cures Act and Information Blocking

   Introduces the federal law framework behind information blocking and the general compliance purpose of the rule. It also explains the timing of the Final Rule and its relevance to healthcare providers.

2. Definition and Compliance Impact

   Summarizes the broad concept of information blocking and the potential consequences discussed in the article. It also notes the provider-focused scope of the rule.

3. Examples of Prohibited Practices

   Describes broad categories of practices addressed by the rule, including restrictions on access, exchange, and use of electronic health information. The section highlights operational patterns that can trigger compliance concerns.

4. USCDI and Required Information Sharing

   Explains the role of USCDI in the rule and the types of information the article says must be made available. It places the discussion in the context of nationwide interoperability.

5. Clinical Notes Covered Under the Final Rule

   Lists the categories of clinical notes discussed in the article as part of the updated sharing expectations. This section focuses on the note types identified by the rule.

6. Exceptions to Information Blocking

   Reviews the general categories of exceptions described in the article and notes that determinations are made based on facts and circumstances. The section addresses when conduct may fall outside the information blocking framework.

7. Provider Compliance Considerations

   Discusses internal policy review, operational gap assessment, and staff education related to the rule. It closes with practical compliance planning considerations for organizations.